[Possibility of a conservative treatment in cancer of the larynx. Preliminary note].
D000109:Acetylcholine / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D007611:Aprotinin; D000109:Acetylcholine
Possibilité d'un traitement conservateur dans le cancer du larynx. Note préliminaire.